ArticleBlood advances2022

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients.

Kristiina Karihtala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.